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pits, and their journey through the endocytic pathwayEndosomal Protein Traffic Meets
begins. In the case of G protein-coupled receptorsNuclear Signal Transduction (GPCRs), internalization results in one of two fates, rapid
recycling to the cell surface or delivery to the lysosomeHead On
and degradation. These fates are largely determined
by the receptor itself and the proteins with which it
associates (Spiegel, 2003; von Zastrow, 2003). Differ-
Rab5 plays a key role in controlling protein traffic ences in these interactions and trafficking can have a
through the early stages of the endocytic pathway. strong influence on signaling by GPCRs as well as type
Previous studies on the modulators and effectors of III TGF- receptors (Chen et al., 2003).
Rab5 protein function have tied the regulation of sev- Ligand-induced clathrin-mediated endocytosis of the
eral signal transduction pathways to the movement epidermal growth factor receptors (EGFRs) also impacts
of protein through endocytic compartments. In the cell signaling. Attenuation of EGFR signaling can be
February 6, 2004, issue of Cell, Miaczynska et al. de- accomplished by the internalization and degradation of
scribe a surprising new link between Rab5 function the receptor (Di Fiore and De Camilli, 2001). However,
and the nucleus by uncovering two new Rab5 effectors like the GPCRs and the type III TGF- receptor, it has
as potential regulators of the nucleosome remodeling become clear that internalization of EGFR and other
and histone deacetylase protein complex NuRD/ receptor tyrosine kinases (RTKs) does not necessarily
MeCP1. result solely in simple downregulation of signaling cas-
cades by the removal of activated receptors from the
Moving proteins through the endocytic pathway is a cell surface. It has been suggested that ligands for some
complex process. Proteins can enter the endocytic RTKs, such as EGFR, may remain associated with the
pathway by several routes, each of which is regulated receptors as they travel through the early stages of the
at multiple points. Once in the cell, protein constituents endocytic pathway, resulting in receptors that remain
then face a number of trafficking choices, including recy- in their active, signaling-competent form. A number of
cling back to the cell surface or traveling deeper into signaling molecules can be found on endocytic struc-
the endocytic pathway. Over the past 10 years, it has tures, including Ras, Raf, and MEK, suggesting that
become increasingly evident that at many steps in the these intracellular endocytic compartments have signal-
endocytic trafficking pathway endocytic cargo can inter- ing potential (Sorkin and Von Zastrow, 2002).
face with and influence many cellular processes (Di Fiore Rab5 is a small GTPase of the Ras superfamily that is
and De Camilli, 2001; Sorkin and Von Zastrow, 2002; responsible for mediating membrane trafficking events
von Zastrow, 2003). Differential trafficking of cell surface through the early stages of the endocytic pathway, and
receptors is one way the movement of proteins through represents a key point at which endocytic trafficking can
the endocytic pathway can influence cellular signal be regulated. In its GTP-bound state, Rab5 facilitates
transduction processes. Once activated by ligand bind- the fusion of the plasma membrane-derived endocytic
vesicles with the early endosome and is also involveding, many receptors are internalized via clathrin-coated
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in early endosome homotypic fusion events. Rab5 is correlates with Rab5 GTP hydrolysis. These results and
others indicate that Rab5 is playing a novel role in APPL1required for constitutive as well as regulated endocytic
events. Activation of Rab5 is achieved by modulating localization by participating in the cytoplasmic seques-
tration of this potential signaling protein.the form of guanine nucleotide bound. In the active state,
Rab5 is bound to GTP, and it is inactive when bound to But what is the nuclear function of these APPL pro-
GDP. A number of studies have shown that activation teins? To address this question, Miaczynska et al. used
of Rab5 (Rab5•GTP) increases flux through the early APPL1 coimmunoprecipitation studies to uncover APPL1
stages of the endocytic pathway. The GDP/GTP cycle interaction partners and identified a number of compo-
of Rab5 is modulated by a number of factors that tie nents of the nucleosome remodeling and histone de-
this cycle to cell signaling events. EGF stimulation of acetylase NuRD/MeCP1 complex. These interactions
cells results in activation of Rin1, a Rab5 guanine nucleo- suggested that APPL proteins may play a role in modu-
tide exchange factor, which in turn increases the endo- lating cell proliferation. This model was supported by
cytosis of the activated EGF receptor. The interaction the finding that reducing APPL1 and/or APPL2 protein
between the EGF signaling pathway and Rab5 is also levels using RNA interference caused a significant re-
influenced by the activity of the Rab5 GTPase activating duction in the number of cells that entered S phase,
protein (GAP), RN-tre. RN-tre GAP activity, which nor- suggesting that the APPL proteins do in fact play an
mally deactivates Rab5 by stimulating the production important role in regulating cell cycle progression.
of Rab5•GDP, is itself subject to negative regulation These data establish a new signaling cascade that
by activated EGFRs. Activation of EGFRs therefore can couples the Rab5 guanine nucleotide binding cycle and
result in the net activation of Rab5 and an increase in the regulation of cell surface receptor traffic with the
EGFR internalization and EGF signal attenuation. spatial regulation of a cell proliferation modulator. The
GPCRs, RTKs, and type III TGF- receptors all inter- segregation of this APPL-signaling portion of Rab5 on
face with components of endocytic machinery to influ- specialized endosomal structures distinct from the Rab5
ence the signaling capacity of these receptors, primarily pool associated with constitutive endocytosis may allow
through modulating receptor trafficking events. A sur- the physical separation required for the independent
prising new interaction between signal transduction and regulation of a Rab GTPase cycle associated with regu-
the endocytic pathway is described by Miaczynska et lating APPL function in response to growth factor stimu-
al. (2004) in the February 6 issue of Cell. They describe lation. The identification of this new EGFR-Rab5-APPL
a novel pathway that utilizes two new Rab5 effectors pathway defines an intriguing new paradigm for Rab5
to propagate signals from early endosomal structures protein function as a participant in signal transduction
directly to the nucleus. These effectors APPL1 (Adaptor systems distinct from its role in vesicular trafficking.
protein containing Ph domain, PTB domain, and Leucine
zipper motif) and APPL2 were identified as interaction
Bruce Horazdovskypartners of an activated version of Rab5 (Rab5•GTPS).
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